US Patent Office to Confirm Kite’s Seminal Eshhar CAR-T Patent – Business Wire (press release)
|
US Patent Office to Confirm Kite’s Seminal Eshhar CAR–T Patent
Business Wire (press release) SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that the United States Patent and Trademark Office (USPTO) has provided a Notice of Intent to issue an Ex Parte Reexamination … |
Medical Xpress |
First ‘haploid’ human stem cells could change the face of medical research
Medical Xpress Haploid human embryonic stem cells. Credit: Azrieli Center for Stem Cells and Genetic Research at Hebrew University. Stem cell research holds huge potential for medicine and human health. In particular, human embryonic stem cells (ESCs), with their … |
Telegraph.co.uk |
GM purple rice could cut risk of cancer
Telegraph.co.uk “Our research provides a high-efficiency vector system for stacking multiple genes for synthetic biology and makes it potentially feasible for engineering complex biosynthesis pathways in the endosperm of rice and other crop plants such as maize, wheat … |
Telegraph.co.uk |
GM purple rice could cut risk of cancer
Telegraph.co.uk “Our research provides a high-efficiency vector system for stacking multiple genes for synthetic biology and makes it potentially feasible for engineering complex biosynthesis pathways in the endosperm of rice and other crop plants such as maize, wheat … |